Case Western Reserve University bioengineer awarded $2.5 million from U.S. Army to boost nanotechnology for treating wounded soldiers and patients with bleeding defects

The research arm of the U.S. Army has awarded Case Western Reserve University  a four-year, $2.5 million grant to advance and optimize his latest nanotechnology to stop bleeding from battlefield injuries. 

The new technology devised by Sen Gupta and his team is called “SanguiStop.� It allows a clot-promoting enzyme called thrombin to be intravenously delivered in a targeted manner to a bleeding area—especially to the site of internal injuries